Regulation of the processing and release of tumor necrosis factor α in a human macrophage cell line

Journal of Leukocyte Biology

Volumn 66, Issue 6, 1999, Pages 968-973

  Nakada Tsukui, Kumiko ^a   Watanabe, Naoko ^a   Kobayashi, Yoshiro ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Metalloprotease; Protease inhibitor; Transport

Indexed keywords

1,10 PHENANTHROLINE; 3,4 DICHLOROISOCOUMARIN; CYTOKINE; IODOACETAMIDE; MATRIX METALLOPROTEINASE INHIBITOR; PHORBOL ESTER; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TUMOR NECROSIS FACTOR;

ARTICLE; CELL COUNT; CELL LINE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN TRANSPORT; REGULATORY MECHANISM;

EID: 0033404973     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.66.6.968     Document Type: Article

References (32)

1. Carswell, K. A., Old, L. J., Kassal, R. L., Green, S., Fiore, N., Williamson, B. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666-3670.
2. Beutler, B., Cerami, A. (1989) The biology of cachectin/TNFα primary mediator of the host response. Annu. Rev. Immunol. 7, 625-655.
3. Vilcek, J., Lee, T. H. (1991) Tumor necrosis factor. J. Biol. Chem. 266, 7313-7316.
4. Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torrance, D. S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., Kronheim, S. R., Peterson, M., Gerhart, M., Kozlosky, C. J., March, C. J., Black, R. A. (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370, 218-220.
5. Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., Woolley, K. (1994) Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370, 555-557.
6. McGeehan, G. M., Becherer, J. D., Bast, R. C., Jr. Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., McElroy, A. B., Nichols, J., Pryzwansky, K. M., Schoenen, K. Sekut, L., Truesdale, A., Verghese, M., Warner, J., Ways, J. P. (1994) Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370, 558-561.
7. Crowe, P. D., Walter, B. N., Mohler, K. M., Otten-Evans, C., Black, R. A., Ware, C. F. (1995) A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181, 1205-1210.
8. Müllberg, J., Durie, F. H., Otten-Evans, C., Alderson, M. R., Rose-John, S., Cosman, D., Black, R. A., Mohler, K. M. (1995) A metalloprotease inhibitor blocks shedding of the IL-6 receptor and p60 TNF receptor. J. Immunol. 155, 5198-5205.
9. Williams, L. M., Gibbons, D. L., Gearing, A., Maini, R. N., Feldman, M., Brennan, F. M. (1996) Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both P55 and P75 TNF receptor shedding and TNFα processing in RA synovial membrane cell cultures. J. Clin. Invest. 97, 2833-2841.
10. Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K., Yagita, H. (1995) Metalloproteinase-mediated release of human Fas ligand. J. Fxp. Med. 182, 1777-1783.
11. Arribas, J., Coodly, L., Vollmer, P., Kishimoto, T. K., Rose-John, S., Massagué, J. (1996) Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271, 11376-11382.
12. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. E., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, Y. Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J., Cerretti, D. P. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385, 729-733.
13. Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. H., Leesnitzer, M. A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J.-L., Warner, J., Willard, D., Becherer, J. D. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385, 733-736.
14. Kim, K.-U., Kwon, O.-J., Jue, D.-M. (1993) Pro-tumour necrosis factor cleavage enzyme in macrophage membrane/particulate. Immunol. 80, 134-139.
15. Robache-Gallea, S., Morand, V., Bruneau, J. M., Schoot, B., Tagat, E., Réalo, E., Chouaib, S., Roman-Roman, S. (1995) In vitro processing of human tumor necrosis factor-α. J. Biol. Chem. 270, 23688-23692.
16. Bazil, V., Strominger, J. L. (1994) Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. J. Immunol. 152, 1314-1322.
17. Bazil, V. (1995) Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol. Today 16, 135-140.
18. Solomon, K. A., Covington, M. B., DeCiceo, C. P., Newton, R. C. (1997) The fate of pro-TNF-α following inhibition of metalloprotease-dependent processing to soluble TNF-α in human monocytes. J. Immunol. 159, 4524-4531.
19. Watanabe, N., Nakada, K., Kobayashi, Y. (1998) Processing and release of tumor necrosis factor α. Eur. J. Biochem. 253, 576-582.
20. Davies, B., Brown, P. D., East, N., Crimmin, M. J., Balkwill, F. R. (1993) A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53, 2087-2091.
21. Kobayashi, Y., Yoshikawa, T., Watanabe, N. (1992) Tumor cytostasis mediated by LPS- or PSK-activated human plastic-adherent peripheral blood mononuclear cells. Cell. Immunol. 144, 358-366.
22. Kobayashi, Y., Appella, E., Yamada, M., Copeland, T., Oppenheim, J. J., Matsushima, K. (1988) Phosphorylation of intracellular precursors of IL-1. J. Immunol. 140, 2279-2287.
23. Laemmli, U. K. (1970) Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
24. Saijo, S., Watanabe, N., Kobayashi, Y. (1995) Comparison of reactivity of monoclonal antibody (3F2) to trimeric tumor necrosis factor (TNF-α) with that to monomeric TNF-α. J. Biochem. 118, 28-32.
25. Stetler-Stevenson, W. G., Aznavoorian, S., Liotta, L. A. (1993) Tumor cell interactions with the extracellular matrix during invasion and metastatis. Annu. Rev. Cell. Biol. 9, 541-573.
26. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61-65.
27. Black, R. A., Durie, F. H., Otten-Evans, C., Miller, R., Slack, J. L., Lynch, D. H., Castner, B., Mohler, K. M., Gerhart, M., Johnson, R. S., Itoh, Y., Okada, Y., Nagase, H. (1996) Relaxed specificity of matrix metalloproteases (MMPs) and TIMP insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting enzyme is not an MMP. Biochem. Biophys. Res. Commun. 225, 400-405.
28. Jue, D.-M., Sherry, B., Luedke, C., Manogue, K. R., Cerami, A. (1990) Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry 29, 8371-8377.
29. Stevenson, F. T., Bursten, S. L., Locksley, R. M., Lovett, D. H. (1992) Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues. J. Exp. Med. 176, 1053-1002.
30. Piocsik, E., Duda, E., Wallach, D. (1995) Phosphorylation of the 20 kDa TNF precursor in monocytic cells and in transfected HeLa cells. J. Inflamm. 45, 152-100.
31. Watanabe, N., Suzuki, J., Kobayashi, Y. (1996) Role of calcium in tumor necrosis factor-α production by activated macrophages. J. Biochem. 120, 1190-1195.
32. Bossi, G., Griffiths, G. M. (1999) Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nature Med. 5, 90-96.